Clinical Trials in Boston

Showing 1421-1440 of 8,503 trials

Health Effects of Substituting Sugary Beverages With Artificially-sweetened Beverages or Water

NCT04567108

Sugar-sweetened beverages (SSBs) contribute an alarming \~7% of calories in the US diet among adults, making SSBs the single largest source of added sugar. However, whether artificially sweetened beverages are a healthful alternative for reducing SSB intake among habitual SSB consumers is unknown. Therefore, the investigators will conduct a 4-arm randomized diet intervention trial to test the effects of substituting SSBs with calorie-free alternatives on body weight and health, among habitual SSB consumers with overweight/obesity.

Body Weight

Brigham and Women's Hospital460 participantsStarted Apr 2021

Boston, Massachusetts, United States

Active Not Recruiting< 1 mile

Establishment of ProNephro AKI (NGAL) Cut Off Value for Risk Assessment of Moderate to Severe Acute Kidney Injury in Adults

NCT06652100

The purpose of this research is to collect blood and urine from adult patients admitted to an intensive care unit. This is to assess the performance of the ProNephro AKI (NGAL) assay (lab test) as an aid to identify patients at risk for acute kidney injury.

Acute Kidney Injury

BioPorto Diagnostics800 participantsStarted Oct 2024

Birmingham, Alabama, United States • Sacramento, California, United States • New Haven, Connecticut, United States +9 more locations

Health Effects of Substituting Sugary Beverages With Artificially-sweetened Beverages or Water

Establishment of ProNephro AKI (NGAL) Cut Off Value for Risk Assessment of Moderate to Severe Acute Kidney Injury in Adults

Find Trials by Condition in Boston

Using Reinforcement Learning to Personalize Electronic Health Record Tools to Facilitate Deprescribing

Percutaneous Image Guided Video-Assisted Thoracic Surgery (VATS) Resection of Lung Lesions

Plasma ExtrAcellular RNAs and Biomarkers of Heart FaiLure During Decongestion: PEARL-HF Study

Study to Assess the Effect of Long-term Treatment With Voxelotor in Participants Who Have Completed Treatment in Study GBT440-031

MARGetuximab Or Trastuzumab (MARGOT)

Study of TNG260 and an Anti-PD Antibody in STK11 Mutated Solid Tumors

Cryocompression for CIPN

An Open-label Study of Encorafenib + Binimetinib in Patients With BRAFV600-mutant Non-small Cell Lung Cancer

A Randomized, Double-Blind, Placebo-Controlled Trial of IkT-148009 in Untreated Parkinson's Disease

Darbepoetin Trial to Improve Red Cell Mass and Neuroprotection in Preterm Infants

A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of a New Formulation of Cabotegravir Long-Acting Administered Intramuscularly in a 4-month Dosing Interval (Q4M)

Study of AVZO-021 in Patients With Advanced Solid Tumors

A Study to Evaluate the Efficacy and Safety of Pemigatinib (INCB054828) in Subjects With Myeloid/Lymphoid Neoplasms With FGFR1 Rearrangement - (FIGHT-203)

A Phase III Study of Ceralasertib Plus Durvalumab Versus Docetaxel in Patients With Non Small Cell Lung Cancer (NSCLC) Whose Disease Progressed On or After Prior Anti PD (L)1 Therapy And Platinum Based Chemotherapy

Natural History Study Protocol in PMM2-CDG (CDG-Ia)

Diagnostic and Therapeutic Applications of Microarrays in Liver Transplantation

UBX-303061 in Subjects With Relapsed/Refractory B-Cell Malignancies

Pharmacogenomics for Better Treatment of Fungal Infections in Cancer